FGF23 and Vitamin D Metabolism

Area of Science:

• Endocrinology
• Bone and Mineral Metabolism
• Renal Physiology

Background:

• Fibroblast growth factor-23 (FGF23) is a bone-derived hormone crucial for phosphate and vitamin D regulation.
• FGF23 primarily targets the kidney, influencing vitamin D activation and degradation.
• A feedback loop exists between FGF23 and 1,25(OH)2D, involving bone and kidney.

Purpose of the Study:

• To review the current understanding of FGF23's molecular mechanisms in regulating vitamin D metabolism.
• To discuss the physiological and pathophysiological roles of these mechanisms.
• To identify knowledge gaps in FGF23 signaling pathways.

Main Methods:

• Review of existing literature on FGF23 and vitamin D metabolism.
• Analysis of genomic and molecular mechanisms.
• Discussion of findings in mice and human studies.

Main Results:

• FGF23 suppresses 1α-hydroxylase and induces 24-hydroxylase in renal tubules.
• Absence of FGF23 signaling disrupts 1α-hydroxylase control, causing 1,25(OH)2D overproduction.
• Significant progress has been made in understanding genomic regulation, but intracellular signaling remains unclear.

Conclusions:

• FGF23 is essential for maintaining normal vitamin D levels through precise control of renal enzymes.
• Further research is needed to elucidate the intracellular signaling cascades downstream of FGF receptors.
• Understanding these mechanisms is vital for both normal physiology and disease states.